Exatecan is a potent camptothecin derivative and a selective topoisomerase I inhibitor utilized in cancer research for the treatment of various solid tumors. This category offers a comprehensive selection… Read more







Exatecan is a potent camptothecin derivative and a selective topoisomerase I inhibitor utilized in cancer research for the treatment of various solid tumors. This category offers a comprehensive selection of reference standards, including the mesylate salt, various degradation products, and specific metabolites required for pharmacological and toxicological studies. These materials are essential for pharmaceutical laboratories to conduct precise impurity profiling and to support the validation of analytical methods during drug development. The range also features stable isotope labelled Exatecan compounds, which act as critical internal standards for accurate quantification in mass spectrometry-based bioanalysis. By providing fully characterized substances for the rigorous assessment of chemical stability and metabolic pathways, these tools enable researchers to maintain high quality control standards throughout the investigation of this therapeutic class.